H.R. 2443 · 114th Congress
To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.
- Stage
- In committee
- Sponsor
- Brett Guthrie
- Introduced
- 2015-05-19
- Latest action
- 2015-05-22 · Referred to the Subcommittee on Health.
Subjects
Administrative law and regulatory procedures
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation